So who/what exactly is, IFRX. Anyone can look up the company, where its from, what they do, and what all their products are. But to make this quick on you rather than spending the 5 seconds to Google or Bing or whatever website you want to use, IFRX is a ‘clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology primarily in the United States and Europe. Its C5a is an inflammatory mediator involved in the enhancement of a variety of autoimmune and other inflammatory diseases.’
As with many Biopharm type companies, much of their assets, resources, and activity is focused on very few items. In the case of IFRX, much of the company was focused on IFX-2, which last week failed clinical trials. As a result, their stock tumbled nearly 92% down to $3. Their old strategy was to focus on these new treatments, now that the stock has crashed and their once lucrative drug has left them just like their stockholders, whats the new strategy? What would you do if you got punched in the face
IFRX 